Voya Investment Management LLC Alkermes Plc. Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

A detailed history of Voya Investment Management LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Voya Investment Management LLC holds 450,621 shares of ALKS stock, worth $12.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

450,621

Previous 440,994 2.18%

Holding current value

$12.5 Million

Previous $10.6 Million 18.68%

% of portfolio

0.02%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.01 - $28.55 $221,517 - $274,850	9,627 Added 2.18%	450,621 $12.6 Million
Q2 2024 Aug 14, 2024	BUY	$23.21 - $27.24 $3.43 Million - $4.03 Million	147,818 Added 50.42%	440,994 $10.6 Million
Q1 2024 May 15, 2024	SELL	$26.4 - $32.56 $378,708 - $467,073	-14,345 Reduced 4.66%	293,176 $7.94 Million
Q4 2023 Feb 14, 2024	BUY	$23.37 - $28.68 $789,251 - $968,580	33,772 Added 12.34%	307,521 $8.53 Million
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $879,764 - $1.04 Million	32,380 Added 13.42%	273,749 $7.67 Million
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $572,808 - $679,729	20,212 Added 9.14%	241,369 $7.55 Million
Q1 2023 May 15, 2023	SELL	$25.31 - $29.02 $3,087 - $3,540	-122 Reduced 0.06%	221,157 $6.23 Million
Q4 2022 Feb 14, 2023	BUY	$21.94 - $26.24 $49,518 - $59,223	2,257 Added 1.03%	221,279 $5.78 Million
Q3 2022 Mar 03, 2023	SELL	$22.0 - $31.87 $49,654 - $71,930	-2,257 Reduced 1.02%	219,022 $4.89 Million
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $29,656 - $42,960	1,348 Added 0.62%	219,022 $4.89 Million
Q2 2022 Aug 15, 2022	SELL	$26.4 - $30.54 $453,129 - $524,188	-17,164 Reduced 7.31%	217,674 $6.48 Million
Q1 2022 May 16, 2022	BUY	$23.07 - $27.99 $3.98 Million - $4.83 Million	172,492 Added 276.67%	234,838 $6.18 Million
Q4 2021 Feb 14, 2022	SELL	$21.47 - $32.08 $12,388 - $18,510	-577 Reduced 0.92%	62,346 $1.45 Million
Q3 2021 Nov 15, 2021	BUY	$23.37 - $32.13 $11,381 - $15,647	487 Added 0.78%	62,923 $1.94 Million
Q2 2021 Aug 16, 2021	SELL	$18.78 - $25.15 $499,247 - $668,587	-26,584 Reduced 29.86%	62,436 $1.53 Million
Q1 2021 May 17, 2021	BUY	$18.21 - $23.2 $1.2 Million - $1.52 Million	65,638 Added 280.72%	89,020 $1.66 Million
Q4 2020 Feb 16, 2021	SELL	$15.39 - $22.1 $392,060 - $562,997	-25,475 Reduced 52.14%	23,382 $466,000
Q3 2020 Nov 16, 2020	SELL	$16.16 - $20.66 $19,181 - $24,523	-1,187 Reduced 2.37%	48,857 $810,000
Q2 2020 Aug 14, 2020	SELL	$13.31 - $19.41 $40,142 - $58,540	-3,016 Reduced 5.68%	50,044 $971,000
Q1 2020 May 15, 2020	BUY	$13.06 - $21.24 $334,753 - $544,423	25,632 Added 93.45%	53,060 $765,000
Q4 2019 Feb 14, 2020	SELL	$17.29 - $21.74 $3,942 - $4,956	-228 Reduced 0.82%	27,428 $560,000
Q2 2019 Aug 14, 2019	SELL	$21.47 - $37.33 $369,670 - $642,747	-17,218 Reduced 38.37%	27,656 $623,000
Q1 2019 May 15, 2019	SELL	$28.4 - $36.49 $74,976 - $96,333	-2,640 Reduced 5.56%	44,874 $1.64 Million
Q4 2018 Feb 14, 2019	SELL	$27.94 - $44.61 $1.56 Million - $2.49 Million	-55,901 Reduced 54.06%	47,514 $1.4 Million
Q3 2018 Nov 14, 2018	BUY	$38.6 - $46.12 $234,996 - $280,778	6,088 Added 6.26%	103,415 $4.39 Million
Q2 2018 Aug 14, 2018	BUY	$40.56 - $51.36 $211,560 - $267,893	5,216 Added 5.66%	97,327 $4.01 Million
Q1 2018 May 15, 2018	BUY	$53.61 - $67.26 $136,276 - $170,974	2,542 Added 2.84%	92,111 $5.34 Million
Q4 2017 Feb 14, 2018	BUY	$47.69 - $55.39 $1.12 Million - $1.31 Million	23,562 Added 35.7%	89,569 $4.9 Million
Q3 2017 Nov 14, 2017	BUY	$49.16 - $54.45 $3.24 Million - $3.59 Million	66,007	66,007 $3.36 Million

Others Institutions Holding ALKS

# of Institutions

361

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.55B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Alkermes Plc. Transaction History